INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS

At present, there are a number of unsolved problems associated with unawareness of the causes and ways to prevent the inefficacy of tumor necrosis factor-α  inhibitors.Objective: to study the causes of secondary inefficacy of infliximab (INF), by analyzing its concentrations and antidrug antibody le...

Full description

Bibliographic Details
Main Authors: O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, M. V. Cherkasova, E. N. Aleksandrova, S. K. Solovyev, Sh. F. Erdes
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2016-09-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2252